Catheter PrecisionVTAK +30.98%28 Gross Margin % is 90.28% as of Mar. 2026, which is 192% above its 10-year median of 30.92. GuruFocus rates VTAK with a GF Score™ of 28/100 and a GF Value™ of $1.72 (Possible Value Trap). The stock has 7 warning signs investors should review. Among 805 Medical Devices & Instruments companies, Catheter Precision ranks better than 96.89% on this metric.
The historical rank and industry rank for Catheter Precision's Gross Margin % or its related term are showing as below:
VTAK'
s Gross Margin % Range Over the Past 10 Years
Min: -6990.91 Med: 30.92 Max: 93.21
Current: 91.52
During the past 10 years, the highestGross Margin % of Catheter Precision was 93.21%. The lowest was -6990.91%. And the median was 30.92%.
VTAK's Gross Margin % is ranked better than 96.89% of 805
companies
in the Medical Devices & Instruments industry
Industry Median: 52.07
vs VTAK: 91.52
Catheter Precision had a gross margin of 90.28% for the quarter that ended in Mar. 2026 => Durable competitive advantage
The 5-Year average Growth Rate of Gross Margin for Catheter Precision was 0.00% per year.
Warren Buffett believes that firms with excellent long term economics tend to have consistently higher margins.
Durable competitive advantage creates a high Gross Margin % because of the freedom to price in excess of cost. Companies can be categorized by their Gross Margin %
1. Greater than 40% = Durable competitive advantage
2. Less than 40% = Competition eroding margins
3. Less than 20% = no sustainable competitive advantage
Consistency of Gross Margin is key
Catheter Precision had a gross margin of 90.28% for the quarter that ended in Mar. 2026 => Durable competitive advantage
Be Aware
If a company loses its competitive advantages, usually its gross margin declines well before its sales declines. Watching Gross Margin % and Operating Margin % closely helps avoid value trap situations.
Catheter Precision Gross Margin % Related Terms
Catheter Precision Gross Margin % Historical Data
* Premium members only.
The historical data trend for Catheter Precision's Gross Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
VTAK vs VYCO, BJDX, NUWE: Gross Margin % Comparison
For the Medical Devices subindustry, Catheter Precision's Gross Margin %, along with its competitors' market caps and Gross Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Catheter Precision Gross Margin % vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Catheter Precision's Gross Margin % distribution charts can be found below:
* The bar in red indicates where Catheter Precision's Gross Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
A positive Gross Profit is only the first step for a company to make a net profit. The gross profit needs to be big enough to also cover related labor, equipment, rental, marketing/advertising, research and development and a lot of other costs in selling the products.
Catheter Precision (VTAK) has a Gross Margin % of 90.28% as of Mar. 2026. Gross margin is the ratio of total gross profit to net sales. View historical data on Catheter Precision and its competitors. This is 192% above median its historical median of 30.92. According to the industry distribution chart, Catheter Precision ranks #25 out of 805 companies in the Medical Devices & Instruments industry, placing it in the top 3.1%.
Is Catheter Precision's Gross Margin % too high?
Catheter Precision's current Gross Margin % of 90.28% is 192% above median its 10-year median of 30.92. The Medical Devices & Instruments industry median Gross Margin % is 52.07. Catheter Precision's value of 90.28% is 73.4% above this industry median. Based on the distribution chart, Catheter Precision ranks #25 out of 805 companies in the Medical Devices & Instruments industry, which is in the top quartile — a strong position relative to peers. Overall, Catheter Precision has a GF Score™ of 28/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Catheter Precision's Gross Margin % compare to VYCO and BJDX?
According to the Medical Devices & Instruments industry distribution chart, Catheter Precision ranks #25 out of 805 companies for Gross Margin %. This places Catheter Precision in the top 3% of its industry — outperforming the majority of peers. The industry median Gross Margin % is 52.07. Catheter Precision's value of 90.28% is 73.4% above this benchmark. While the company's 10-year median is 30.92 vs. the industry median of 52.07, Catheter Precision has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Gross Margin % for a Medical Devices & Instruments company?
The median Gross Margin % among Medical Devices & Instruments companies is 52.07, based on 805 companies in the industry. Companies in the top quartile (top 25%) have a Gross Margin % significantly above this median, while those in the bottom quartile fall well below. However, Gross Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Catheter Precision's current Gross Margin % of 90.28% is 73.4% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Gross Margin % mean?
A high Gross Margin % can signal that a stock is expensive relative to its fundamentals. Gross margin is the ratio of total gross profit to net sales. View historical data on Catheter Precision and its competitors. For the Medical Devices & Instruments industry, the median Gross Margin % is 52.07 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Catheter Precision's current Gross Margin % is 90.28%, which is 192% above median its own 10-year median of 30.92. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Catheter Precision stock overvalued right now?
Based on GuruFocus' analysis, Catheter Precision (VTAK) is currently considered Possible Value Trap. The stock's GF Value™ is $1.72, compared to a current price of $1.21 — trading 29.9% below its estimated fair value. The current Gross Margin % is 90.28%, which is 192% above median its 10-year median of 30.92 and 73.4% above the Medical Devices & Instruments industry median of 52.07. Catheter Precision's overall GF Score™ is 28/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Gross Margin % calculated?
Gross Margin % is calculated from a company's financial statements. For Catheter Precision (VTAK), the current Gross Margin % is 90.28% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Catheter Precision (VTAK) Overvalued in 2026?
Based on GuruFocus' analysis, Catheter Precision stock appears to be undervalued.
The current stock price of $1.21 is trading 29.9% below its estimated GF Value™ of $1.72.
GuruFocus considers Catheter Precision to be Possible Value Trap.
Key valuation signals for VTAK:
Gross Margin %: 90.28% (192% above median its 10-year median of 30.92)
GF Value™: $1.72 vs. price of $1.21 (29.9% below fair value)
Industry Position: 73.4% above the Medical Devices & Instruments median (#25 of 805)
No single metric tells the full story. See the VTAK stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Catheter Precision Inc is engaged in the design, manufacture, and sale of medical technologies focused in the field of cardiac electrophysiology, or EP. The company's two primary products include the VIVO System and LockeT. The VIVO System, which is an acronym for View into Ventricular Onset System(VIVO or VIVO System), is a non-invasive imaging system that offers 3D cardiac mapping to help with localizing the sites of origin of idiopathic ventricular arrhythmias in patients with structurally normal hearts prior to EP procedures. Its newest product, LockeT, is a suture retention device indicated for wound healing by distributing suture tension over a larger area in the patient in conjunction with a figure of eight suture closure.
28GF Score
Get the complete analysis for VTAK
Gross Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
VTAK has been successfully added to your 
